Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07492043

Breast Tumour Size Measurement by Field Cycling Imaging

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
12 (estimated)
Sponsor
University of Aberdeen · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can accurately estimate tumour size in patients with a type of breast cancer called ductal carcinoma in situ (DCIS). The main question it aims to answer is: Can FCI accurately estimate DCIS lesion size compared with histology results? Participants will have a standard MRI scan and an FCI scan before undergoing surgery to remove the tumour.

Conditions

Interventions

TypeNameDescription
OTHERField-Cycling Imaging research scanBaseline FCI scan
OTHER3T MRI research scanBaseline MRI scan

Timeline

Start date
2026-04-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2026-03-25
Last updated
2026-03-25

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07492043. Inclusion in this directory is not an endorsement.

Breast Tumour Size Measurement by Field Cycling Imaging (NCT07492043) · Clinical Trials Directory